DOCSLIB.ORG

CDC/ATSDR) Freedom of Information Act (FOIA) Request Log January-June 2019

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text

Load more

Description of document: Centers for Disease Control and Prevention and Agency for Toxic Substances and Disease Registry (CDC/ATSDR) Freedom of Information Act (FOIA) request log January-June 2019 Requested date: 18-August-2019 Release date: 28-August-2019 Posted date: 09-December-2019 Source of document: FOIA Request CDC/ATSDR Attn: FOIA Office, MS-D54 1600 Clifton Road, NE Atlanta, GA 30333 Fax: (404) 235-1852 Email: [email protected] The governmentattic.org web site (“the site”) is a First Amendment free speech web site, and is noncommercial and free to the public. The site and materials made available on the site, such as this file, are for reference only. The governmentattic.org web site and its principals have made every effort to make this information as complete and as accurate as possible, however, there may be mistakes and omissions, both typographical and in content. The governmentattic.org web site and its principals shall have neither liability nor responsibility to any person or entity with respect to any loss or damage caused, or alleged to have been caused, directly or indirectly, by the information provided on the governmentattic.org web site or in this file. The public records published on the site were obtained from government agencies using proper legal channels. Each document is identified as to the source. Any concerns about the contents of the site should be directed to the agency originating the document in question. GovernmentAttic.org is not responsible for the contents of documents published on the website. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service Centers for Disease Control and Prevention (CDC) Atlanta GA 30333 August 28, 2019 Sent Via Email This letter is regarding to your Centers for Disease Control and Prevention and Agency for Toxic Substances and Disease Registry (CDC/ATSDR) Freedom oflnformation Act (FOIA) request of August 18, 2019, assigned #19-01086-FOIA, for: "The CDC/ATSDR FOIA Office provides monthly reports to CDC/ATSDR Management on FOIA Administration, FOIA Requests, and FOIA backlogs. I request a copy of the most recent five such monthly reports." A responsive record in the form of two Excel spreadsheets is being released to you in part. After a careful review of all data, some information was withheld from release pursuant to 5 U.S.C. §552 Exemption (b)(6). EXEMPTION6 Exemption 6 protects information in personnel and medical files and similar files when disclosure would constitute a clearly unwarranted invasion of personal privacy. The information that has been withheld under Exemption 6 consists of personal information, such as names of private citizens, laboratory sample numbers, and other private information. We have determined that the individuals to whom this information pertains have a substantial privacy interest in withholding it. In addition, please be informed that our FOIA office does not furnish a monthly report to management; instead, we post our monthly statistics on our FOIA website found at https://www.cdc.gov/od/foia/resources/ references.htm. You may contact our FOIA Public Liaison at 770-488-6277 for any further assistance and to discuss any aspect of your request. Additionally, you may contact the Office of Government Information Services (OGIS) at the National Archives and Records Administration to inquire about the FOIA mediation services they offer. The contact information for OGIS is as follows: Office of Government Information Services, National Archives and Records Administration, 8601 Adelphi Road-OGIS, College Park, Maryland 20740-6001, e-mail at [email protected]; telephone at 202-741-5770; toll free at 1-877-684-6448; or facsimile at 202-741-5769. If you are not satisfied with the response to this request, you may administratively appeal by writing to the Deputy Agency Chief FOIA Officer, Office of the Assistant Secretary for Public Affairs, U.S. Page 2 Department of Health and Human Services, Hubert H. Humphrey Building, 200 Independence Avenue, Suite 729H, Washington, D.C. 20201. Please mark both your appeal letter and envelope "FOIA Appeal." Your appeal must be postmarked or electronically transmitted by November 26, 2019. Sincerely, Roger Andoh CDC/ATSDRFOIA Officer Office of the Chief Operating Officer Phone: (770) 488-6399 Fax: ( 404) 235-1852 Enclosures #19-01086-FOIA FOIA Log January 1 2019 - March 31 2019 FOIA Log- January 1, 2019-March 31, 2019 Request ID Received Date Requester Name Organization Request Description 19-00191-FOIA 1/9/2019 Keys (#22458017), Clay - copies of FOIA requests # 13-00242, 13-00247, 13-00293, 13-00326 19-00207-FOIA 1/2/2019 Jabour, Melissa Atlee Hall, LLP Any and all information, documents and/or reports generated and/or produced as a result of the Center for Disease Control and Prevention's on- site investigation of WellSpan York Hospital from July 26 through August 14, 2015, including, but not limited to the "Trip Report" or "Epi-2" report; and any and all documents and/or reports generated as a result of the CDC's inspection of any LivaNova or Sorin 3T heater-cooler devices, which were owned by York Hospital. (Date Range for Record Search: From 07/26/2015 To 01/01/2016) 19-00213-FOIA 1/25/2019 Freudenthal, Emmanuel - respective copy of the following records: 1. A copy of all of contracts between the CDC and any subcontractors involved in the collection, transport, processing, storage and shipping of Ebola samples from Liberia, Sierra Leone and/or Guinea between 2013 and now. 2. A list of security incidents related to the transportation, storage, tracking, and use of Ebola samples collected in Liberia, Sierra Leone and/or Guinea. 3. A list of all the projects funded by the CDC with ‘Ebola’ in the name or the description between 2013 and today. 4. The final reports, if they exist, or the annual reports of all the projects funded by the CDC under the Consolidated and Further Continuing Appropriations Act, 2015 (H.R. 83) and the HHS Public Health and Social Services Emergency Fund (PHSSEF). i.e. those that have the word ‘Ebola’ and that would be the projects that are listed in the reply to Point 3. 19-00217-FOIA 1/9/2019 Finnegan, Adam - respective copies of the following conference sponsored by the CDC and FDA: Centers for Disease Control and Prevention. Proceedings of the First National Conference on Lyme Disease Testing, Dearborn, Michigan, 1990. Centers for Disease Control and Food and Drug Administration, Washington, DC, November 1–2, 1990. 19-00226-FOIA 1/14/2019 Jabour, Robin Atlee Hall, LLP Any and all raw data, data collection, background data and reports that pertain to an article written by Meghan Lyman, et al., entitled "Invasive Nontuberculous Mycobacterial Infections Among Cardiothoracic Surgical Patients Exposed to Heater-Cooler Devices," published in May 2017 in Emerging Infectious Diseases journal. (Date Range for Record Search: From 07/01/2015 To 12/01/2017) 19-00228-FOIA 1/23/2019 Fultz, Diane Atlee Hall, LLP All raw data, testing results from patient isolates, testing results from Sorin 3T heater-cooler units, and any results from comparison testing between the machine isolates and patient isolates from Hershey Medical Center in Hershey, Pennsylvania. (Date Range for Record Search: From 07/01/2015 To 12/01/2017) 19-00229-FOIA 1/23/2019 Fultz, Diane Atlee Hall, LLP All raw data, testing results from patient isolates, testing results from Sorin 3T heater-cooler units, and any results from comparison testing between the machine isolates and patient isolates from Penn Presbyterian Medical Center in Philadelphia, Pennsylvania. (Date Range for Record Search: From 07/01/2015 To 12/01/2017) Page 1 of 40 Pages FOIA Log January 1 2019 - March 31 2019 FOIA Log- January 1, 2019-March 31, 2019 Request ID Received Date Requester Name Organization Request Description 19-00231-FOIA 1/10/2019 Hagemann, Hannah The Monterey County Herald Pursuant to the federal Freedom of Information Act, 5 U.S.C. 552, I request the following information: all documents, budgets, studies, reports related to the health risks of continued, multi-year exposure to wildfire smoke. I would like to receive the information in electronic format. I would like to receive the information in electronic format. I am making the request as a reporter and student currently studying at the UC Santa Cruz Science Writing Graduate program; this request is made as part of newsgathering and not for commercial use. As a representative of the news media I am only required to pay for the direct cost of duplication after the first 100 pages. I ask that you waive any and all applicable fees associated with this request. Through this request, I am gathering information on firefighter health and safety. Release of this information is in the public interest because it will contribute significantly to the public understanding of government operations and activities, particularly on the realm of firefighter health, and the health risks of continued exposure to wildfire smoke. If you deny this request for a fee waiver, please advise me in advance of the estimated charges if they are to exceed $100. If my request is denied in whole or part, I ask that you justify all deletions by reference to specific exemptions of the Act. I will also expect you to release all segregable portions of otherwise exempt material. I reserve the right to appeal your decision to withhold any information or to deny a waiver of fees. I also ask that you provide expedited review of this request which concerns a matter of urgency. The information sought relates to a currently unfolding story, specifically, that the first study investigating the respiratory health of forest firefighters is happening now. Second, delaying release of the information harms the public interest in knowing what actions are being taken to understand the health risks of firefighters’ exposure to wildfire.
Recommended publications
  • Coronavirus Preparedness and Response Hearing

    Coronavirus Preparedness and Response Hearing

    CORONAVIRUS PREPAREDNESS AND RESPONSE HEARING BEFORE THE COMMITTEE ON OVERSIGHT AND REFORM HOUSE OF REPRESENTATIVES ONE HUNDRED SIXTEENTH CONGRESS SECOND SESSION MARCH 11–12, 2020 (A TWO DAY HEARING) Serial No. 116–96 Printed for the use of the Committee on Oversight and Reform ( Available on: http://www.govinfo.gov, oversight.house.gov or docs.house.gov U.S. GOVERNMENT PUBLISHING OFFICE 40–428 PDF WASHINGTON : 2020 COMMITTEE ON OVERSIGHT AND REFORM CAROLYN B. MALONEY, New York, Chairwoman ELEANOR HOLMES NORTON, District of JIM JORDAN, Ohio, Ranking Minority Member Columbia PAUL A. GOSAR, Arizona WM. LACY CLAY, Missouri VIRGINIA FOXX, North Carolina STEPHEN F. LYNCH, Massachusetts THOMAS MASSIE, Kentucky JIM COOPER, Tennessee MARK MEADOWS, North Carolina GERALD E. CONNOLLY, Virginia JODY B. HICE, Georgia RAJA KRISHNAMOORTHI, Illinois GLENN GROTHMAN, Wisconsin JAMIE RASKIN, Maryland JAMES COMER, Kentucky HARLEY ROUDA, California MICHAEL CLOUD, Texas RO KHANNA, California BOB GIBBS, Ohio DEBBIE WASSERMAN SCHULTZ, Florida CLAY HIGGINS, Louisiana JOHN P. SARBANES, Maryland RALPH NORMAN, South Carolina PETER WELCH, Vermont CHIP ROY, Texas JACKIE SPEIER, California CAROL D. MILLER, West Virginia ROBIN L. KELLY, Illinois MARK E. GREEN, Tennessee MARK DESAULNIER, California KELLY ARMSTRONG, North Dakota BRENDA L. LAWRENCE, Michigan W. GREGORY STEUBE, Florida STACEY E. PLASKETT, Virgin Islands FRED KELLER, Pennsylvania JIMMY GOMEZ, California ALEXANDRIA OCASIO-CORTEZ, New York AYANNA PRESSLEY, Massachusetts RASHIDA TLAIB, Michigan KATIE PORTER, California DEB HAALAND, New Mexico DAVID RAPALLO, Staff Director DANIEL REBNORD, Subcommittee Staff Director ALEXANDRA GOLDEN, Chief Health Counsel RICHARD TRUMKA, Subcommittee Staff Director AMY STRATTON, Clerk CHRISTOPHER HIXON, Minority Staff Director CONTACT NUMBER: 202-225-5051 (II) CONTENTS MARCH 11 AND 12, 2020 (DAY 1 AND DAY 2) Page WITNESSES Dr.
  • COVID-19 Compilation – May 11, 2020 Courtesy of Cornerstone Government Affairs

    COVID-19 Compilation – May 11, 2020 Courtesy of Cornerstone Government Affairs

    COVID-19 Compilation – May 11, 2020 Courtesy of Cornerstone Government Affairs Common Acronyms Centers for Disease Control and Prevention (CDC), World Health Organization (WHO), National Institutes of Health (NIH), Personal Protective Equipment (PPE), Department of Health and Human Services (HHS), Department of Defense (DOD), Department of Homeland Security (DHS), United States Department of Agriculture (USDA), Central Command (CENTCOM), Department of Housing and Urban Development (HUD), Centers for Medicare and Medicaid Services (CMS), Transportation Security Administration (TSA), Department of Veterans Affairs (VA), Assistant Secretary for Preparedness and Response (ASPR), Biomedical Advanced Research and Development Authority (BARDA) Washington, D.C. • The White House has directed West Wing staff to wear masks/face coverings after at least two aides tested positive for COVID-19. • Sen. Lamar Alexander (R-TN), Drs. Tony Fauci and Robert Redfield, and FDA Commissioner Stephen Hahn are all self-isolating. Tomorrow's Senate HELP Committee hearing will still take place, but each of the aforementioned individuals will join virtually. • HUD Sec. Ben Carson announced the allocation of $1 billion in CARES Act funding through the Community Development Block Grant (CDBG) program. You can view the allocation formula here. • COVID-19 hearings in Congress this week (memos will be available upon request): o Tuesday (5/12) . 10:00 AM – Senate HELP Hearing: "COVID-19: Safely Getting Back to Work and Back to School" . 2:30 PM – Senate Judiciary Hearing: “Examining liability during the COVID-19 pandemic” o Wednesday (5/13) . 10:00 AM – Senate Commerce Hearing: "The State of Broadband Amid the COVID-19 Pandemic" o Thursday (5/14) . 10:00 AM – House Energy and Commerce Hearing: “Protecting Scientific Integrity in the COVID-19 Response” • The CDC remained busy through the weekend, updating and publishing additional documents on its dashboard.
  • Ebola: Basics About the Disease

    Ebola: Basics About the Disease

    Ebola: Basics About the Disease Sarah A. Lister Specialist in Public Health and Epidemiology October 3, 2014 Congressional Research Service 7-5700 www.crs.gov R43750 Ebola: Basics About the Disease n March 2014, global health officials recognized an outbreak of Ebola virus disease (EVD) in Guinea, West Africa. In retrospect, officials determined that the outbreak began in December I2013, and spread to the adjacent countries of Liberia and Sierra Leone. In September 2014, the U.S. Centers for Disease Control and Prevention (CDC) confirmed the first EVD case diagnosed in the United States,1 heightening concerns among some who fear the disease could spread in American communities.2 This report discusses EVD in general, including symptoms, modes of transmission, incubation period, and treatments; presents projections of the future course of the outbreak; and lists additional CRS products, including products focused on the situation in West Africa. Unless otherwise cited, information in this report is drawn from Ebola information pages of CDC3 and the World Health Organization (WHO).4 Figure 1. Ebola Virus Particle The Ebola Virus and EVD The Ebola virus is named after the Ebola River, near where the virus was discovered in 1976 in Zaire, now known as the Democratic Republic of the Congo (DRC). It is in the filovirus family, so called because of its filamentous shape. EVD is also known as Ebola hemorrhagic fever. The disease sometimes causes hemorrhage (i.e., bleeding) from body openings, but this symptom is not consistent. Five strains of Ebola virus have been identified. The Zaire strain is responsible for the current outbreak in West Source: Colorized transmission electron micrograph Africa.
  • CDC's Response to the West African Ebola Epidemic

    CDC's Response to the West African Ebola Epidemic

    2014–2015 CDC’S RESPONSE TO THE West African Ebola Epidemic 2014 –2015 Sierra Leone’s Deputy Minister of Foreign Affairs and International Cooperation, Dr. Ebun Strasser-King, and Dr. Tom Frieden, CDC Director, meet when she visited CDC in November 2014. “It’s like fighting a forest fire. The Long Road Leave behind one burning ember The 2014 Ebola epidemic in West Africa is the first in history. The first case was reported in Guinea and the epidemic could re-ignite. in March 2014, and the disease spread in the neighboring countries of Liberia and Sierra Leone. Over That ember could be one case the span of a year, the Ebola epidemic has caused more than 10 times as many cases of Ebola than undetected, one contact not the combined total of all those reported in previous Ebola outbreaks. As the outbreak became more traced or healthcare worker not widespread, travel-associated cases appeared in Nigeria, Mali, Senegal, and even countries outside effectively protected, or one burial Africa, including the United States. Overall, nine countries have reported cases of Ebola, more than ceremony conducted unsafely.” 27,000 people have had suspected, probable, or confirmed Ebola, and more than 11,000 have died. Dr. Tom Frieden, CDC Director, August 20, 2014 These numbers are likely to be even higher, as many cases have gone undiagnosed and unreported. Not only has this epidemic been unprecedented, but so has the public health response launched by CDC and its partners. Within a week of the initial report of Ebola, CDC had an expert team on the ground in Guinea.
  • Smoking, Vaping & Covid-19: What Are Health Experts Saying?

    Smoking, Vaping & Covid-19: What Are Health Experts Saying?

    SMOKING, VAPING & COVID-19: WHAT ARE HEALTH ORGANIZATIONS AND EXPERTS SAYING? U.S. Centers for Disease Control and Prevention “Being a current or former cigarette smoker can make you more likely to get severely ill from COVID-19. If you currently smoke, quit. If you used to smoke, don’t start again. If you’ve never smoked, don’t start.” (“Coronavirus Disease 2019 (COVID-19) – People with Certain Medical Conditions,” CDC, Apr. 29, 2021) "We also know that tobacco smoking can increase the risk for developing lung disease, making it harder to recover from lung diseases or infections such as COVID-19. And so we do encourage you to have your patients quit smoking or think about that, and they can call 1-800-QUIT-NOW or visit the CDC website at http://www.cdc.gov/quit for help or more information about that." (Dr. Georgina Peacock, "COVID-19 Response At Risk Task Force Lead, CDC, Underlying Medical Conditions and People at Higher Risk for Coronavirus Disease 2019 (COVID-19)," CDC Clinician Outreach and Communication Activity (COCA) Call, Mar. 27, 2020) Dr. Nora Volkow, Director of the U.S. National Institute on Drug Abuse “Because it attacks the lungs, the coronavirus that causes COVID-19 could be an especially serious threat to those who smoke tobacco or marijuana or who vape. … Thus far, deaths and serious illness from COVID-19 seem concentrated to those who are older and who have underlying health issues, such as diabetes, cancer, and respiratory conditions. It is therefore reasonable to be concerned that compromised lung function or lung disease related to smoking history, such as chronic obstructive pulmonary disease (COPD), could put people at risk for serious complications of COVID-19.
  • Special Assistant to the CEO – Resolve to Save Lives Vital Strategies

    Special Assistant to the CEO – Resolve to Save Lives Vital Strategies

    Special Assistant to the CEO – Resolve to Save Lives Vital Strategies Vital Strategies (VS), based in New York City, is an international public health organization. We develop and oversee programs to strengthen public health systems and address leading causes of morbidity and mortality, providing expertise in project implementation and management, strategic communications, epidemiology and surveillance, and other core public health capacities. Our specific programs include road safety, obesity prevention, tobacco control, and activities to strengthen public health data systems and the use of public health data to guide policy and decision-making. Activities are based in low and middle-income countries and cities in Africa, Latin America, Asia and the Pacific. Please visit our website at www.vitalstrategies.org to find out more about our work. Background: Resolve to Save Lives is a groundbreaking 5-year, $225 million global health initiative that aims to save 100 million lives by reducing preventable deaths from cardiovascular disease – the world’s leading cause of death – and to prevent infectious disease epidemics. Resolve to Save Lives is housed within Vital Strategies, a global health organization that works in 60 countries to address the most challenging health issues to improve the quality of life for people around the world. To find out more, please visit www.resolvetosavelives.org. The Position: Resolve to Save Lives seeks a Special Assistant to support its President and CEO, Dr. Tom Frieden. This is a full-time position based in New York City. Vital Strategies offers competitive compensation based on prior experience and qualifications as well as comprehensive benefits. The successful candidate will have the ability to work in an entrepreneurial, fast-paced environment to support an important, large-scale global public health effort.
  • Crisis Communications and Vaccine Uptake in Fragile African Settings

    Crisis Communications and Vaccine Uptake in Fragile African Settings

    WEBINAR | JUNE 22, 2021 Launch of the Report: Crisis Communications Speakers TOM FRIEDEN and Vaccine Uptake in CHINWE LUCIA OCHU Fragile African Settings YOUSSEF CHERIF Moderators THE CHALLENGES at this juncture are complex. Panel- WILMOT G. JAMES ists Tom Frieden, Chinwe Lucia Ochu, and Youssef Che- rif discussed effective methodologies for communicating ROBERT Y. SHAPIRO COVID-19 risk to drive distribution and uptake of vac- cines in fragile state settings—whether due to instability, post war conditions, or internal strife. Event presented by ROBERT Y. SHAPIRO1: Welcome everyone to the launch of the report, Crisis Communication and Vaccine THE CENTER FOR PANDEMIC RESEARCH Uptake in Fragile African Settings. I would like to thank the partners for today’s event: the Center for Pandemic Research at the Institute for Social and Economic Re- search and Policy (ISERP) at Columbia University, Front- Event Partners line Nurses from the Center for the Study of Social Dif- ference, Columbia School of Nursing, the Program in Vaccine Education at the Vagelos College of Physicians and Surgeons, the Columbia Global Centers in Nairobi and Tunis, Columbia Climate School and The Earth Insti- FRONTLINE NURSES tute, and The Academy of Political Science. My name is Bob Shapiro. I am president of The Academy of Political Science, a member of the executive committee of the Center for Pandemic Research at ISERP, and professor of PROGRAM IN VACCINE EDUCATION political science and international and public affairs at Columbia. I would like to introduce our speakers today. Wilmot James will be a speaker and co-moderator with me for NAIROBI AND TUNIS today’s session.
  • Most Countries Aren't Prepared for the Next Epidemic

    Most Countries Aren't Prepared for the Next Epidemic

    Most Countries Aren’t Prepared for the Next Epidemic PreventEpidemics.org Highlights Gaps in Preparedness and Encourages Action to Save Lives June 21, 2018, Aspen, CO, USA – The world will face another unpredictable epidemic, but most countries are not ready to find, stop, and prevent its spread. A new website, PreventEpidemics.org, spotlights gaps in preparedness and highlights actions countries, donors, activists, and organizations can take to fill them. An infectious disease can spread from one community to any country in the world in just 36 hours, but as PreventEpidemics.org shows, most countries have not yet taken the steps needed to prepare for this risk. The website is being presented tomorrow at the annual Aspen Ideas Spotlight Health Festival by Dr. Tom Frieden, former US CDC Director and now President and CEO of Resolve to Save Lives, an initiative of the global health organization Vital Strategies, and Amanda McClelland, RN, MPH, its Senior Vice President, who coordinated frontline Ebola response during the 2014 Ebola epidemic. The website is the first to provide a single ReadyScore for every country based on their ability to find, stop and prevent epidemics; it also provides advocacy tools to help make health protection a priority. “By the end of this year, nearly 100 countries will have completed a rigorous, transparent assessment of how prepared they are for an epidemic – but there has been too little support from the global community and countries to close life-threatening gaps,” says Dr. Tom Frieden. “It’s not a matter of if there will be another global epidemic, but when.
  • Brenda Fitzgerald Appointed As New CDC Director

    Brenda Fitzgerald Appointed As New CDC Director

    Brenda Fitzgerald appointed as new CDC director 10 July 2017 | News She replaces Dr. Anne Schuchat, who has been the acting CDC director and acting ATSDR administrator since January 20 Public health commissioner of Georgia and two-time republican candidate for Congress Brenda Fitzgerald has been appointed as the next director of federal government's top public health agency Centers for Disease Control and Prevention (CDC). Appointed by Dr. Tom Price, Health and Human Services Secretary, she is the 17th Director of the Centers for Disease Control and Prevention (CDC) and Administrator of the Agency for Toxic Substances and Disease Registry (ATSDR). She replaces Dr. Anne Schuchat, who has been the acting CDC director and acting ATSDR administrator since January 20. Secretary Price said, “I am extremely proud and excited to announce Dr. Brenda Fitzgerald as the new Director of the CDC. Having known Dr. Fitzgerald for many years, I know that she has a deep appreciation and understanding of medicine, public health, policy and leadership—all qualities that will prove vital as she leads the CDC in its work to protect America’s health 24/7. We look forward to working with Dr. Fitzgerald to achieve President Trump's goal of strengthening public health surveillance and ensuring global health security at home and abroad. Congratulations to Dr. Fitzgerald and her family.” “Additionally, I’d like to extend my deep appreciation and thanks to Dr. Anne Schuchat for her exemplary service as acting director of the CDC. We thank Dr. Schuchat and her team for their dedication in our public health efforts to keep Americans safe and for their work to ensure a seamless transition.
  • Covid-19 Situation Report

    Covid-19 Situation Report

    COVID-19 SITUATION REPORT March 26, 2020 | Joshua Sharfstein, MD HTTP://CORONAVIRUS.JHU.EDU © 2020 Johns Hopkins University. All rights reserved 3 The U.S. Has Followed the Trajectory of Other Heavily Impacted Countries More cases in U.S. per day than any country. More cases reported per day in U.S. than at peak of Chinese epidemic. Source: CSSE COVID Dashboard, Johns Hopkins © 2020 Johns Hopkins University. All rights reserved 4 What’s New This Week New York For Mayors There has been Even if a slower rise than in a major surge of New York, other cities could follow seriously ill patients in a similar path. Strong control New York City. measures remain necessary. © 2020 Johns Hopkins University. All rights reserved 5 What’s New This Week Therapeutics For Mayors Rising demand for chloroquine – despite Instead of chasing after no high-quality studies demonstrating unproven therapies, mayors effectiveness – has created shortages for should support the gathering patients who need these medications for of high-quality evidence to find other conditions. out what works. © 2020 Johns Hopkins University. All rights reserved 6 What’s New This Week Many biotech companies are investing in COVID-19 vaccines I-Mab Biopharma BioNTech and Applied DNA Sciences Clover and GSK Altimmune Completes announce research Announces Fosun Pharma form Vaxart Announces Subsidiary, LineaRx, First Development Development of TJM2 Moderna’s Work on a Australia ramps up Integral Molecular COVID-19 vaccine Initiation of and Takis Biotech collaboration to Tonix Pharmaceuticals
  • IDSA Comments on CDC Proposed Quarantine Rule (PDF)

    IDSA Comments on CDC Proposed Quarantine Rule (PDF)

    October 14, 2016 President Johan S. Bakken, MD, PhD, FIDSA The Honorable Dr. Tom Frieden Director US Centers for Disease Control and Prevention President-Elect 1600 Clifton Road William G. Powderly, MD, FIDSA Atlanta, GA 30329 Dear Dr. Frieden, Paul G. Auwaerter, MD, MBA, FIDSA The Infectious Diseases Society of America (IDSA) appreciates the opportunity to comment on the Notice of Proposed Rulemaking (NPRM) for Control of Communicable Diseases: Secretary Penelope H. Dennehy, MD, FIDSA Interstate and Foreign. IDSA appreciates that the Centers for Disease Control and Prevention (CDC) is working to codify and increase transparency around the practices related to controlling communicable diseases. In today’s ever more connected world, the ability to Treasurer effectively and quickly respond to domestic and global outbreaks with appropriate and Helen W. Boucher, MD, FIDSA measured protocols strengthens our public health and biosecurity. IDSA also believes it is essential to ensure public cooperation through transparent, evidence-based policies that are Immediate Past President well communicated and ensure fair treatment for all individuals. Stephen B. Calderwood, MD, FIDSA Infectious diseases (ID) physicians are on the front lines of domestic and global outbreak preparedness and response, including the recent Ebola virus outbreak in West Africa. ID Judith A. Aberg, MD, FIDSA physicians also routinely deal with outbreaks of other diseases that can require quarantine, such as tuberculosis, as well as extraordinary cases like Ebola virus infections. While IDSA is Barbara D. Alexander, MD, MHS, enthusiastic about many of the proposed changes outlined in the NPRM, there are a few FIDSA sections for which we recommend adjustments to help ensure optimal outcomes.
  • Mark Your Calendars: Immunize Georgia Conference September 15, 2017 Atlanta, GA

    Mark Your Calendars: Immunize Georgia Conference September 15, 2017 Atlanta, GA

    Volume 7, Issue 8 August 2017 Follow us on: SHANRITA MCCLAIN EPIC IMMUNIZATION PROGRAM COORDINATOR 404-881-5054 [email protected] Mark Your Calendars: Immunize Georgia Conference September 15, 2017 Atlanta, GA Georgia Pediatric Nurses & Practice Manager Associations Fall Meeting October 13, 2017 Cobb Galleria Centre, Atlanta, GA Pediatrics on the Parkway (GAAAP) Fall CME Meeting October 26-28, 2017 Westin Buckhead Atlanta, GA August in National Immunization Awareness month National Immunization Awareness Month (NIAM) is an annual observance held in August to highlight the importance of vaccination for people of all ages. NIAM was established to encourage people of all ages to make sure they are up to date on the vaccines recommended for them. Communities have continued to use the month each year to raise awareness about the important role vaccines play in preventing serious, sometimes deadly, diseases. NIAM is sponsored by the National Public Health Information Coalition (NPHIC). For more information on the ob- servance, visit NPHIC’s NIAM website. Are you or someone you know an immunization expert? Do you enjoy sharing your knowledge with others? If you answered yes, you could become a trainer for EPIC. We provide training on the program curriculum, use of the pro- gram equipment (laptop and projector), a stipend for your time, and some great tips for presenting to adult learners. Please contact Shanrita McClain at (404) 881-5054 more information. Slight drop in measles vaccinations could triple infections in U.S. kids Lisa Rapaport FILE PHOTO: A measles vaccine is seen at Venice Family Clinic in Los Angeles, California February 5, 2015.Lucy Ni- cholson (Reuters Health) - Just a 5 percent decline in measles vaccination rates could triple the number of young children who get infected with the virus in the U.S., according to a study highlighting the risks of parents refusing to vac- cinate their kids.